TipRanks on MSN
IBIO, RLMD, SEE, OLLI, Invivyd trending with analysts
Analysts are intrested in these 5 stocks: ( ($IBIO) ), ( ($RLMD) ), ( ($SEE) ), ( ($OLLI) ) and ( ($IVVD) ). Here is a breakdown of their recent ...
Abstract: This paper explores a novel class of event-triggered mechanisms for nonlinear systems utilizing output-feedback control. Initially, an output-feedback state observer is designed to estimate ...
Saudi Gazette on MSN
SFDA approves Qfitlia for bleeding prevention in hemophilia patients
The Saudi Food and Drug Authority (SFDA) has approved Qfitlia (Fitusiran) for the prevention or reduction of bleeding episodes in adults and adolescents aged 12 and above with hemophilia A or B, ...
A key step to deliver RNAi therapeutics to diverse cell types and tissues beyond the liver from the collaboration of ...
Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...
Vial's INHBE siRNA is a first-in-class, liver-targeted (GalNAc-conjugated) siRNA therapy that silences INHBE and its gene product, Activin E -- Leading key opinion leaders (KOL ...
Norgine, a leading European specialty pharmaceutical company, today announced an exclusive licensing agreement under which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback